Project description

I am a member of the Leukemia Service at MSKCC. My projects build upon the van den Brink Lab’s experience in immunology in patients with hematologic malignancies to study T cell immunity in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Using advanced sequencing and imaging approaches, including T cell receptor sequencing, I am particularly focused on studying the bone marrow immune environment with the goal of ultimately improving immunotherapy strategies for AML and MDS. My work also includes studies in recipients of allogeneic hematopoietic cell transplants, a long-standing immunotherapy for AML and MDS patients.

Grants/Awards/Highlights

• Louis V. Gerstner, Jr. Physician Scholars Program, 2022
• Leukemia SPORE Career Development Award, 2022
• ASH Abstract Achievement Award 2020
• ASCO Young Investigator Award 2020
• MSK Clinical Scholar T32 2019
• ASH HONORS Award 2016
• American Society of Nephrology Foundation for Kidney Research Student Scholar Grant 2013
• Alpha Omega Alpha 2015
• Phi Beta Kappa 2010

Education

• Memorial Sloan Kettering Cancer Center Hematology/Oncology Fellowship, 2021
• Columbia University Internal Medicine Residency, 2018
• Columbia University College of Physicians and Surgeons, MD 2015
• Harvard College, A.B. 2010